# Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

> **NCT00576316** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 201 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Symbicort Turbuhaler 160/4.5

## Key facts

- **NCT ID:** NCT00576316
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2010-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576316, "Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00576316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*